Who
Robert J. Meyer
Director
Company insider
Files Form 4 as: Director, Avalyn Pharma; Director, Chimerix; Director, Translate Bio.
In numbers
- Trades disclosed
- 33
- Buys
- 5
- Sells
- 0
- Bought
- $74K
- Sold
- $0
- Companies
- 3
- Companies where not an officer
- 3
- First trade
- 28 Mar 2018
- Last trade
- 15 Sep 2026
- Last filed
- 17 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 15 Sep 2026filed 17 Sep 2026 | AVLN Avalyn Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —31,182 at $0.00 | filing |
| 15 Sep 2026filed 17 Sep 2026 | AVLN Avalyn Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —31,182 at $0.00 | filing |
| 21 Apr 2025filed 21 Apr 2025 | Chimerixoption or derivative | SEC FORM 4 Code D | —42,000 | filing |
| 21 Apr 2025filed 21 Apr 2025 | Chimerixoption or derivative | SEC FORM 4 Code D | —21,000 | filing |
| 21 Apr 2025filed 21 Apr 2025 | Chimerixoption or derivative | SEC FORM 4 Code D | —21,000 | filing |
| 21 Apr 2025filed 21 Apr 2025 | Chimerixoption or derivative | SEC FORM 4 Code D | —35,000 | filing |
| 21 Apr 2025filed 21 Apr 2025 | Chimerixoption or derivative | SEC FORM 4 Code D | —35,000 | filing |
| 21 Apr 2025filed 21 Apr 2025 | Chimerixoption or derivative | SEC FORM 4 Code D | —50,000 | filing |
| 21 Apr 2025filed 21 Apr 2025 | Chimerixoption or derivative | SEC FORM 4 Code D | —60,000 | filing |
| 21 Apr 2025filed 21 Apr 2025 | Chimerixoption or derivative | SEC FORM 4 Code D | —60,000 | filing |
| 21 Apr 2025filed 21 Apr 2025 | Chimerix | SEC FORM 4 Code D | $301K35,150 at $8.55 | filing |
| 20 Jun 2024filed 21 Jun 2024 | Chimerixoption or derivative | SEC FORM 4 Code A | —60,000 at $0.00 | filing |
| 9 Jun 2023filed 12 Jun 2023 | Chimerixoption or derivative | SEC FORM 4 Code A | —60,000 at $0.00 | filing |
| 8 May 2023filed 10 May 2023 | Chimerix | SEC FORM 4 Bought | $9,9758,750 at $1.14 | filing |
| 23 Jun 2022filed 24 Jun 2022 | Chimerixoption or derivative | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 19 May 2022filed 20 May 2022 | Chimerix | SEC FORM 4 Bought | $21K9,981 at $2.06 | filing |
| 19 May 2022filed 20 May 2022 | Chimerix | SEC FORM 4 Bought | $2,9091,419 at $2.05 | filing |
| 14 Sep 2021filed 14 Sep 2021 | Translate Biooption or derivative | SEC FORM 4 Code S | —18,900 at $0.00 | filing |
| 14 Sep 2021filed 14 Sep 2021 | Translate Biooption or derivative | SEC FORM 4 Code S | —37,800 at $0.00 | filing |
| 14 Sep 2021filed 14 Sep 2021 | Translate Biooption or derivative | SEC FORM 4 Code S | —18,900 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.